Literature DB >> 15808750

Clinical and genetic issues in familial dilated cardiomyopathy.

Emily L Burkett1, Ray E Hershberger.   

Abstract

Idiopathic dilated cardiomyopathy (IDC) is characterized by left ventricular dilatation and systolic dysfunction after known causes have been excluded. Idiopathic dilated cardiomyopathy occurring in families, or familial dilated cardiomyopathy (FDC), may occur in 20% to 50% of IDC cases. Sixteen genes have been shown to cause autosomal dominant FDC, but collectively may account for only a fraction of genetic causation; it is anticipated that additional genes causative of FDC will be discovered. Familial dilated cardiomyopathy demonstrates incomplete penetrance, variable expression, and significant locus and allelic heterogeneity, making clinical and genetic diagnosis complex. Echocardiographic and electrocardiographic screening of first-degree relatives of individuals with IDC and FDC is indicated, as detection and treatment are possible before the onset of advanced symptomatic disease. Genetic counseling for IDC and FDC is also indicated to assist with family evaluations for genetic disease and with the uncertainty and anxiety surrounding the significance of clinical and genetic evaluation. Genetic testing is not yet commonly available, but its emergence will provide new opportunities for presymptomatic diagnosis.

Entities:  

Mesh:

Year:  2005        PMID: 15808750     DOI: 10.1016/j.jacc.2004.11.066

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  116 in total

1.  Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy.

Authors:  Ana Morales; Thomas Painter; Ran Li; Jill D Siegfried; Duanxiang Li; Nadine Norton; Ray E Hershberger
Journal:  Circulation       Date:  2010-05-10       Impact factor: 29.690

2.  Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.

Authors:  Neal K Lakdawala; Lisa Dellefave; Charles S Redwood; Elizabeth Sparks; Allison L Cirino; Steve Depalma; Steven D Colan; Birgit Funke; Rebekah S Zimmerman; Paul Robinson; Hugh Watkins; Christine E Seidman; J G Seidman; Elizabeth M McNally; Carolyn Y Ho
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

Review 3.  Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.

Authors:  Ray E Hershberger
Journal:  J Cardiovasc Transl Res       Date:  2008-05-20       Impact factor: 4.132

4.  Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy.

Authors:  Jose Renato Pinto; Jill D Siegfried; Michelle S Parvatiyar; Duanxiang Li; Nadine Norton; Michelle A Jones; Jingsheng Liang; James D Potter; Ray E Hershberger
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

5.  Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.

Authors:  Marwan M Refaat; Steven A Lubitz; Seiko Makino; Zahid Islam; J Michael Frangiskakis; Haider Mehdi; Rebecca Gutmann; Michael L Zhang; Heather L Bloom; Calum A MacRae; Samuel C Dudley; Alaa A Shalaby; Raul Weiss; Dennis M McNamara; Barry London; Patrick T Ellinor
Journal:  Heart Rhythm       Date:  2011-10-17       Impact factor: 6.343

Review 6.  Screening children with a family history of sudden cardiac death.

Authors:  Christopher Wren
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

7.  Gene expression profiling of dilated cardiomyopathy in older male EP4 knockout mice.

Authors:  Pamela Harding; Xiao-Ping Yang; James Yang; Ed Shesely; Quan He; Margot C LaPointe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

8.  Skin deep: what can the study of dermal fibroblasts teach us about dilated cardiomyopathy?

Authors:  Brian C Jensen
Journal:  J Mol Cell Cardiol       Date:  2009-12-11       Impact factor: 5.000

9.  Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy.

Authors:  Michael Jerosch-Herold; David C Sheridan; Jessica D Kushner; Deirdre Nauman; Donna Burgess; Diana Dutton; Rami Alharethi; Duanxiang Li; Ray E Hershberger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-25       Impact factor: 4.733

10.  Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy.

Authors:  Chad Brodt; Jill D Siegfried; Mark Hofmeyer; Jose Martel; Evadnie Rampersaud; Duanxiang Li; Ana Morales; Ray E Hershberger
Journal:  J Card Fail       Date:  2013-04       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.